CSAM Scientific Conference presentation on Hep C care innovations
Recently, at the annual Canadian Society of Addiction Medicine (CSAM-SMCA) 2022 Scientific Conference, we presented on how we were able to improve Hepatitis C (HCV) care at scale during the COVID-19 pandemic using several innovative, tech-based interventions. As Canada’s trusted community partner for opioid agonist treatment (OAT) CATC offers seamless HCV screening and linkage to […]
Continue Reading